GC Biopharma will acquire ABO Holdings for $96 million to enhance its immunoglobulin medication Alyglo's supply chain.

On election day, Tuesday, November 5, Americans will choose between former President Donald Trump and current Vice President ...

The combined company, which will pair Chroma’s epigenetic editing with Nvelop’s non-viral particles, has raised $75 million ...

Biopharma leaders at companies developing blood cancer therapies say we shouldn’t be afraid to use the four-letter word: cure ...

Morgan Stanley lowered the firm’s price target on Zenas BioPharma (ZBIO) to $35 from $40 and keeps an Overweight rating on the shares. The firm ...

In a report released today, Vikram Purohit from Morgan Stanley maintained a Buy rating on Zenas BioPharma, Inc. (ZBIO – Research Report), with ...

A downtrend has been apparent in Can-Fite Biopharma Ltd (CANF) lately. While the stock has lost 26.8% over the past week, it ...

Vor Biopharma Inc (VOR) stock saw a modest uptick, ending the day at $1.04 which represents a slight increase of $0.22 or 26.83% from the prior close of $0.82. The stock opened at $0.86 and touched a ...

President-elect Donald Trump and his incoming administration are unlikely to attempt a wholesale restructuring of U.S.

As part of an SEC settlement, a Houston pharmaceutical company won't have to pay a civil penalty — but two of its former top ...

As reported by the South China Morning Post today, Everest Medicines (HKEX 1952.HK) is accelerating its journey to become a leading biopharmaceutical company in the Asia-Pacific region, driven by ...

Sutro Biopharma Inc (STRO) stock saw a decline, ending the day at $2.35 which represents a decrease of $-0.46 or -16.37% from the prior close of $2.81. The stock opened at $2.79 and touched a low of ...